Skip to content

Moxibustion in a Randomized Trial for Version of Breech Position From Week 32

Moxibustion for Version of Singleton Breech Position Before Term

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02251886
Enrollment
200
Registered
2014-09-29
Start date
2003-01-31
Completion date
2014-09-30
Last updated
2017-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presentation; Breech, With External Version Before Labor

Brief summary

Moxibustion was tested for version of a breech position in singleton pregnancies. The women were randomized in week 32 to either moxibustion on acupuncture point Bl 67 daily in 15-20 minutes or no moxibustion. In week 36-37 the fetal position was checked and external cephalic version was offered for those still in breech position. The randomization was stratified for primigravida and multiparae separately. The randomization was made with a random number even and odd numbers indicating moxibustion or not. The randomization result was hidden in a sealed, non-transparent envelope on the obstetrical department and drawn when the woman gave informed consent to the study.

Detailed description

Moxibustion was tested for version of a breech position in singleton pregnancies. The women were randomized in week 32 to either moxibustion on acupuncture point Bl 67 daily in 15-20 minutes or no moxibustion. In week 36-37 the fetal position was checked and external cephalic version was offered for those still in breech position. The randomization was stratified for primigravida and multiparae separately. The randomization was made with a random number even and odd numbers indicating moxibustion or not. The randomization result was hidden in a sealed, non-transparent envelope on the obstetrical department and drawn when the woman gave informed consent to the study. Sample size calculation gave 45 women in each group, based on alfa 0.05 and beta 20 under condition of a 30 % effect of moxibustion vs. 20 % of spontaneous version in the control group in primiparae and 60 % in multiparae, respectively. Thus, 4 times 45 women in each group were sought. Only women who had performed three treatments were judged under the principle of intention to treat. Exclusion criteria at inclusion in week 32 was bleeding in 2nd and 3rd trimester, placenta insufficiency, cervical shortening, premature rupture of membranes, preeclampsia, elevated blood pressure, pelvic insufficiency, low placental position, uterine malformations, former uterine corrective surgery and known fetal morbidity

Interventions

OTHERMoxibustion in primiparae

Number of primiparae participants with Version of Fetal Breech Position to Cephalic Position up to 4 weeks after treatment

OTHERMoxibustion in multiparae

Number of multiparae participants with Version of Fetal Breech Position to Cephalic Position up to 4 weeks after treatment

Sponsors

Herning Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* pregnant women with singleton breech position of their babies

Exclusion criteria

* vaginal bleeding in 2nd and 3rd trimester, placental insufficiency, cervical shortening, premature rupture of membranes, preeclampsia, high blood pressure, pelvic insufficiency, low placental position, placenta praevia, uterine malformations, previous corrective uterine surgery, known fetal morbidity

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Version of Fetal Breech Position to Cephalic Position up to 4 Weeks After Treatment4 weeksNumber of Participants with Version of Fetal Breech Position to Cephalic Position up to 4 weeks after treatment

Participant flow

Participants by arm

ArmCount
Moxibustion in Primiparae
Moxibustion added to the acupuncture point Bl 67 for 15-20 minutes daily from week 32 to 36 in primiparae Moxibustion in primiparae: Moxibustion at acupuncture point Bl 67 daily for 15-20 minutes for 3-4 weeks in multiparae
48
Moxibustion in Multiparae
Moxibustion added to the acupuncture point Bl 67 for 15-20 minutes daily from week 32 to 36 in multiparae Moxibustion in multiparae: Moxibustion at acupuncture point Bl 67 daily for 15-20 minutes for 3-4 weeks in multiparae
54
Control Primiparae
No intervention. Routine control schedule for primiparae with midwife
44
Control Multiparae
No intervention. Routine control schedule for multiparae with midwife
54
Total200

Baseline characteristics

CharacteristicControl MultiparaeTotalMoxibustion in MultiparaeControl PrimiparaeMoxibustion in Primiparae
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
54 Participants200 Participants54 Participants44 Participants48 Participants
Age, Continuous31 years
STANDARD_DEVIATION 3
30 years
STANDARD_DEVIATION 4
31 years
STANDARD_DEVIATION 3
29 years
STANDARD_DEVIATION 4
28 years
STANDARD_DEVIATION 4
Gender
Female
54 Participants200 Participants54 Participants44 Participants48 Participants
Gender
Male
0 Participants0 Participants0 Participants0 Participants0 Participants
Gestational age231 days
STANDARD_DEVIATION 7
230 days
STANDARD_DEVIATION 6
230 days
STANDARD_DEVIATION 6
230 days
STANDARD_DEVIATION 7
229 days
STANDARD_DEVIATION 6
Region of Enrollment
Denmark
54 participants200 participants54 participants44 participants48 participants
Weight74 kg
STANDARD_DEVIATION 15
76 kg
STANDARD_DEVIATION 14
78 kg
STANDARD_DEVIATION 14
75 kg
STANDARD_DEVIATION 12
76 kg
STANDARD_DEVIATION 14

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
0 / 480 / 540 / 440 / 54
serious
Total, serious adverse events
0 / 480 / 540 / 440 / 54

Outcome results

Primary

Number of Participants With Version of Fetal Breech Position to Cephalic Position up to 4 Weeks After Treatment

Number of Participants with Version of Fetal Breech Position to Cephalic Position up to 4 weeks after treatment

Time frame: 4 weeks

ArmMeasureValue (NUMBER)
Moxibustion in PrimiparaeNumber of Participants With Version of Fetal Breech Position to Cephalic Position up to 4 Weeks After Treatment34 participants
Moxibustion in MultiparaeNumber of Participants With Version of Fetal Breech Position to Cephalic Position up to 4 Weeks After Treatment25 participants
Control PrimiparaeNumber of Participants With Version of Fetal Breech Position to Cephalic Position up to 4 Weeks After Treatment34 participants
Control MultiparaeNumber of Participants With Version of Fetal Breech Position to Cephalic Position up to 4 Weeks After Treatment25 participants
p-value: 0.4895% CI: [0.77, 1.76]Chi-squared
p-value: 195% CI: [0.69, 1.46]Chi-squared

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026